Anticorps Polyclonal de lapin anti-VE-cadherin/CD144

VE-cadherin/CD144 Polyclonal Antibody for WB, IHC, IF/ICC, FC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IHC, IF/ICC, FC, ELISA

Conjugaison

Non conjugué

Publications(29)

N° de cat : 27956-1-AP

Synonymes

VE-cadherin, 7B4, 7B4 antigen, Cadherin 5, Cadherin-5

---

Galerie de données de validation

• 

  WB analysis using 27956-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 27956-1-AP (VE-cadherin antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human placenta using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 27956-1-AP (VE-cadherin antibody) at dilution of 1:1000 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human placenta using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 27956-1-AP (VE-cadherin antibody) at dilution of 1:1000 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human breast cancer using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 27956-1-AP (CDH5 antibody) at dilution of 1:400 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human breast cancer using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 27956-1-AP (CDH5 antibody) at dilution of 1:400 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human lung cancer using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer tissue slide using 27956-1-AP (VE-cadherin antibody) at dilution of 1:400 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human lung cancer using 27956-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer tissue slide using 27956-1-AP (VE-cadherin antibody) at dilution of 1:400 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IF Staining of HUVEC using 27956-1-AP

  Immunofluorescent analysis of (4% PFA) fixed HUVEC cells using VE-cadherin/CD144 antibody (27956-1-AP) at dilution of 1:200 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2).

• 

  IF Staining of HUVEC using 27956-1-AP

  Immunofluorescent analysis of (4% PFA) fixed HUVEC cells using VE-cadherin/CD144 antibody (27956-1-AP) at dilution of 1:200 and CoraLite®594-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-4).

• 

  FC experiment of HUVEC using 27956-1-AP

  1X10^6 HUVEC cells were surface stained with 0.4 ug Anti-Human VE-cadherin (27956-1-AP) and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000, or 0.4 ug Control Antibody. Cells were not fixed.

---

Applications testées

• Résultats positifs en WB: cellules HUVEC, tissu placentaire humain
• Résultats positifs en IHC: tissu placentaire humain, tissu de cancer du poumon humain, tissu de cancer du sein humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF/ICC: cellules HUVEC,
• Résultats positifs en cytométrie: cellules HUVEC,

Dilution recommandée

• Western Blot (WB): WB : 1:1000-1:4000
• Immunohistochimie (IHC): IHC : 1:500-1:2000
• Immunofluorescence (IF)/ICC: IF/ICC : 1:50-1:500
• Flow Cytometry (FC): FC : 0.40 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• WB: See 16 publications below
• IHC: See 3 publications below
• IF: See 12 publications below

Informations sur le produit

27956-1-AP cible VE-cadherin/CD144 dans les applications de WB, IHC, IF/ICC, FC, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: VE-cadherin/CD144 Protéine recombinante Ag27487
• Nom complet: cadherin 5, type 2 (vascular endothelium)
• Masse moléculaire calculée: 88 kDa
• Poids moléculaire observé: 120-140 kDa
• Numéro d’acquisition GenBank: NM_001795
• Symbole du gène: VE-cadherin
• Identification du gène (NCBI): 1003
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Cadherins are a family of transmembrane glycoproteins that mediate calcium-dependent cell-cell adhesion and play an important role in the maintenance of normal tissue architecture. Vascular endothelial cadherin (VE-cadherin), also known as Cadherin-5 (CDH5) or CD144, is a member of the type II classical cadherin family of cell adhesion proteins (PMID: 21269602). VE-cadherin is expressed specifically in endothelial cells and mediates homophilic adhesion in the vascular endothelium (PMID: 1522121; 8555485; 21269602). VE-cadherin plays a role in the organization of lateral endothelial junctions and in the control of permeability properties of vascular endothelium (PMID: 1522121). VE-cadherin has also been shown to be required for angiogenesis (PMID: 16473763; 18162609). The calculated molecular weight of VE-cadherin is 88 kDa and the apparent molecular weight of 120-140 kDa is higher due to post-translational glycosylation and phosphorylation (PMID: 10460833; 29894844). Full-length VE-cadherin can be proteolytically cleaved to generate a fragment of 90-100 kDa (PMID: 9786462; 22064597).

Publications

Species	Application	Title
	WB	Nat Commun; FNIP1 abrogation promotes functional revascularization of ischemic skeletal muscle by driving macrophage recruitment; Authors - Zongchao Sun
	WB	Adv Healthc Mater; Colon-Targeted Ginseng Polysaccharides-Based Microspheres for Improving Ulcerative Colitis via Anti-Inflammation and Gut Microbiota Modulation; Authors - De-Yang Huo
human	IF	Bioengineering (Basel); Organotypic 3D Co-Culture of Human Pleura as a Novel In Vitro Model of Staphylococcus aureus Infection and Biofilm Development; Authors - Olga Kurow
	WB	Pharmaceuticals (Basel); CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway; Authors - Hai-Zhou Ji
	WB	World J Diabetes; Tongxinluo promotes endothelium-dependent arteriogenesis to attenuate diabetic peripheral arterial disease; Authors - Jiao-Jiao Gu
	WB	Front Cell Infect Microbiol; Analysis of miRNAs Involved in Mouse Heart Injury Upon Coxsackievirus A2 Infection.; Authors - Zhaoke Wu

{{ptg:RelatedPrimaryAntibodies}}